Press Release

IRI Names New Members to Board of Directors

Issued by Insured Retirement Institute [IRI]

Sept. 23, 2021

WASHINGTON, D.C. – The Insured Retirement Institute (IRI) today announced changes to its board of directors.

Joining the IRI board of directors are Blake Bostwick, CEO, Individual Solutions, Transamerica, and John Schobel, CEO & Founder, RegEd.

Bostwick heads Transamerica’s Individual Solutions team, leading the company’s product manufacturing strategies for annuities, funds, and insurance solutions that are provided to customers and their financial professionals across the U.S. Bostwick also leads the distribution of investments, life and supplemental health insurance through the organization’s retail affiliates, including Transamerica Agency Network, Transamerica Financial Advisors, and World Financial Group.

As a founding member of RegEd, Schobel has transformed the company into the market-leading provider of enterprise SaaS solutions that address the needs of the financial services industry including compliance management, agent onboarding, licensing, registration, and education and training. Under his leadership and direction, RegEd ascended from a single-product company into the industry leader it is today, serving hundreds of enterprise clients and more than one million end-users.

“We welcome two strong and committed advocates for the insured retirement industry, Blake Bostwick and John Schobel,” said Wayne Chopus, IRI President and CEO.  “Each brings unique perspectives to an engaged and passionate group of industry leaders on the IRI board of directors. I know both are enthusiastic about the opportunity to serve our industry in this role, and I look forward to their contributions to IRI’s leadership.”

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.